Matches in Wikidata for { <http://www.wikidata.org/entity/Q95287870> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q95287870 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95287870 description "scientific article published on 18 May 2020" @default.
- Q95287870 description "wetenschappelijk artikel" @default.
- Q95287870 description "наукова стаття, опублікована 18 травня 2020" @default.
- Q95287870 name "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 name "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 type Item @default.
- Q95287870 label "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 label "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 prefLabel "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 prefLabel "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 P1433 Q95287870-F4D4B8A0-4C29-4EA3-924B-B246DEFC9EDE @default.
- Q95287870 P1476 Q95287870-9BBDF41A-AD5C-4874-BE93-5CE94072C3AA @default.
- Q95287870 P2093 Q95287870-017617A1-CB22-450A-A98D-83B03F717048 @default.
- Q95287870 P2093 Q95287870-1B0E2560-8D16-4D85-A900-345D0C15758A @default.
- Q95287870 P2093 Q95287870-73C751B9-7BAD-493C-A1C7-CA9490D5A329 @default.
- Q95287870 P2093 Q95287870-92152942-D523-48F0-BC78-93A583696603 @default.
- Q95287870 P2093 Q95287870-EAB5D116-DF88-4833-9BE7-0E7C76495AE5 @default.
- Q95287870 P2093 Q95287870-F1336A4F-B13C-4136-82A9-7092BB3A8AE3 @default.
- Q95287870 P2093 Q95287870-FDD85531-896E-4837-A4D6-B49B66E69E7A @default.
- Q95287870 P31 Q95287870-745A128F-4A40-4896-BBC1-72CE0FBA3DAF @default.
- Q95287870 P356 Q95287870-7450B632-3735-47B1-ADB9-10E51B78CB30 @default.
- Q95287870 P577 Q95287870-BC820B21-3D10-4E02-9C44-E640A0EC273C @default.
- Q95287870 P698 Q95287870-A98E5C7D-AB2C-48F7-8A3B-AED24965F5D4 @default.
- Q95287870 P921 Q95287870-F9AB581C-C945-4370-80C2-F3FC118B23C3 @default.
- Q95287870 P356 BJD.19224 @default.
- Q95287870 P698 32421854 @default.
- Q95287870 P1433 Q4970191 @default.
- Q95287870 P1476 "A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail" @default.
- Q95287870 P2093 "A Tavakkol" @default.
- Q95287870 P2093 "B Elewski" @default.
- Q95287870 P2093 "R Pollack" @default.
- Q95287870 P2093 "R Schotzinger" @default.
- Q95287870 P2093 "S Brand" @default.
- Q95287870 P2093 "S Curelop" @default.
- Q95287870 P2093 "T Degenhardt" @default.
- Q95287870 P31 Q13442814 @default.
- Q95287870 P356 "10.1111/BJD.19224" @default.
- Q95287870 P577 "2020-05-18T00:00:00Z" @default.
- Q95287870 P698 "32421854" @default.
- Q95287870 P921 Q269829 @default.